Muscle Protein Synthesis & Preservation Pathways

Muscle protein synthesis and preservation pathways collectively refer to the interconnected molecular signaling networks—most notably the **Akt/mTORC1 axis, IGF-1 receptor pathway, and TGFβ/myostatin pathway**—that regulate protein synthesis, breakdown, and turnover within skeletal muscle tissue. These pathways integrate signals from nutrition (amino acids, especially essential amino acids and branched-chain amino acids), hormones (such as insulin and IGF-1), mechanical loading (exercise), and growth factors to determine muscle mass balance (hypertrophy vs. atrophy). Key nodes include **mTORC1**, which coordinates translational efficiency and ribosome biogenesis, and is activated by Akt downstream of the IGF-1 receptor, while antagonized by myostatin/Smad2/3 signaling. These pathways are therapeutic targets for muscle-wasting conditions, but as a group, do not constitute a single druggable molecule or receptor[1][3][4][6].

Other names

Muscle hypertrophy pathwaysMuscle atrophy pathwaysmTOR/Akt signaling axisMuscle anabolic/catabolic signaling

mTOR inhibitors block protein synthesis and muscle growth IGF-1 agonists and insulin activate Akt/mTOR signaling, enhancing protein synthesis Myostatin inhibitors release inhibition on muscle growth (TGFβ pathway blockade) Amino acid supplements (especially essential amino acids and BCAAs) activate mTORC1 to induce protein synthesis